User:Mr. Ibrahem/Tirzepatide

Tirzepatide, sold under the brand name Mounjaro, is a medication used to treat type 2 diabetes and obesity. It is used together with diet and exercise. It is given by weekly injection under the skin.

Common side effects include nausea, diarrhea, constipation, and abdominal pain. Other side effects may include pancreatitis, low blood sugar, allergic reactions, and gallbladder disease. Use in pregnancy may harm the baby. It is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor activator and increases insulin release with food.

Tirzepatide was approved for medical use in the United States, Europe, and the United Kingdom in 2022. In the United States it costs about 1,000 USD for 4 weeks as of 2022.